Bionik Laboratories Corp. Stock

Equities

BNKL

US09074A2087

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 08:10:00 2023-11-29 pm EST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Bionik Laboratories Corp. -.--% -.--%
Sales 2022 1.27M Sales 2023 1.81M Capitalization 2.8M
Net income 2022 -10M Net income 2023 -4M EV / Sales 2022 0.17 x
Net cash position 2022 1.99M Net Debt 2023 1.98M EV / Sales 2023 2.65 x
P/E ratio 2022
-0.21 x
P/E ratio 2023
-0.56 x
Employees 12
Yield 2022 *
-
Yield 2023
-
Free-Float 20%
More Fundamentals * Assessed data
Dynamic Chart
1 year
0.00
Extreme 0
1.45
3 years
0.00
Extreme 0
2.90
5 years
0.00
Extreme 0
7.00
10 years
0.00
Extreme 0
450.05
More quotes
Managers TitleAgeSince
Chief Executive Officer 44 20-11-29
Founder 33 10-01-07
Director of Finance/CFO - 21-08-31
Members of the board TitleAgeSince
Founder 33 10-01-07
Director/Board Member 68 17-08-31
Chief Executive Officer 44 20-11-29
More insiders
Bionik Laboratories Corp. is a robotics company, which provides neurological functional recovery solutions to stroke survivors and others with neurological and mobility challenges. It uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and deliver recovery for patients with neurological or mobility impairments. It has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development. Its InMotion ARM, and InMotion ARM/HAND products are robotic therapies for the upper limbs. In addition to these fully developed, clinical rehabilitation solutions, it is also developing InMotion Home, which is an upper extremity product that allows the patient to extend their therapy for as long as needed while rehabilitating at home. Its other products are InMotion Robots and InMotion CONNECT.
More about the company